New!
Elixirgen Scientific's Alzheimer's Disease Patient-derived human iPSC Neuron Panel

Disease panels for predicting the efficacy of drugs in clinical trials

  • Comprehensive Data Associated with Patient-Derived Cells : RNA and Whole-exome sequencing results including APOE status, along with essential endpoint analyses
  • Assay Ready: Optimized for immediate use, allowing researchers to begin experiments without the need for extensive assay validation
  • Biomarker Identification: Utilizing omics data for patient stratification
Use Our Cells

Use Our Cells:

Human iPSC-Derived Cells

Ready-to-use iPSC-derived cells including a variety of neurons as well as neural precursor cells, astrocytes, and vascular endothelial cells from healthy donors and patients.

Use Our Kits

Use Our Kits:

iPSC Differentiation Kits

Proprietary transcription factor-based technology allows for rapid, reproducible differentiation of iPSCs into the desired cell and tissue types.

Use Our Service

Use Our Service:

iPSC Differentiation & Assay

All of our iPSC differentiation services begin with a free consultation with one of our experts so that we can tailor our services with assays of your choice to best fit your needs.

The Elixirgen Difference

Elixirgen Scientific products and services generate results fast, within 1-2 results.

Fast

Use our kits or use our service to generate differentiated cell and tissue types from human iPSCs and ESCs in just 1-2 weeks.

any-cells

Flexible

Our workflows mean any lab can easily differentiate any iPS or ES cell line, expanding the options for cell type, disease state, and genetic background.
functional

Functional

Elixirgen’s iPSC differentiation technology produces functional and more physiologically relevant cell-based models that better represent human biology.
scalable

Scalable

Produce virtually limitless amounts of identical human cells with our quick and easy differentiation technology—ideal for high content screening applications.

Functional iPSC-derived cells in any lab. Faster. Easier.

Functional iPSC-derived cells in any lab. Faster. Easier.

With Elixirgen’s proprietary transcription factor-based Quick-Tissue™ technology, you can quickly and easily generate cells and tissues from human iPS and ES cells. Quick-Tissue™ is a complete reagent set that enables differentiation in as little as 1-2 weeks using a workflow that can be mastered by any life science lab.

Educational Resources

The team at Elixirgen is committed to your success. If you don’t find the protocol, publication, or answer to your question in our Educational Resources section, feel free to contact us.

Contact Elixirgen Scientific